Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
PolyTherics
PolyTherics
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Antitope to produce cell line for Baylor Institute
For novel therapeutic dendritic-cell-targeting vaccine
Finance
PolyTherics merges with Antitope
London-based biopharmaceuticals developer also receives new investment to accelerate growth
Ingredients
PolyTherics extends application of PolyPEG to more companies
Extension of collaboration will investigate further applications of patented polymer
Research & Development
PolyTherics and Spirogen announce research collaboration
To develop novel antibody drug conjugates for the treatment of cancer
Research & Development
PolyTherics acquires Warwick Effect Polymers
Expands polyethylene glycol (PEG) technology portfolio
Research & Development
PolyTherics receives grant to develop novel fusion proteins
Project aims to develop a way of fusing proteins that is quicker and cheaper
Research & Development
PolyTherics wins funding to further PEGylation development
PolyTherics, a UK user of biomedical polymers to optimise pharmaceuticals, has completed an investment round of
Subscribe now